2023
DOI: 10.1016/j.reuma.2022.01.004
|View full text |Cite
|
Sign up to set email alerts
|

Disease control in patients with ankylosing spondylitis in real clinical practice in Spain: Results of the MIDAS study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(4 citation statements)
references
References 21 publications
0
4
0
Order By: Relevance
“…Two different cohorts were included: 313 patients with AS and 313 patients with psoriatic arthritis. The inclusion and exclusion criteria, study design, study procedures and main results have already been published ( 10 ). The main objective of the MIDAS study was to evaluate the percentage of patients with controlled disease activity.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations
“…Two different cohorts were included: 313 patients with AS and 313 patients with psoriatic arthritis. The inclusion and exclusion criteria, study design, study procedures and main results have already been published ( 10 ). The main objective of the MIDAS study was to evaluate the percentage of patients with controlled disease activity.…”
Section: Methodsmentioning
confidence: 99%
“…In the MIDAS study, a BASDAI score < 4 was considered low disease activity and a BASDAI score ≤ 2 as disease remission ( 11 ). Disease control was defined as reaching at least a BASDAI of low disease activity ( 10 ). Disease activity was also measured through the Ankylosing Spondylitis Disease Activity Score index using C-reactive protein (ASDAS-CRP), and the percentage of patients with an ASDAS-CRP score < 2.1 (low disease activity) and < 1.3 (inactive disease) was calculated.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations